Role of IL-18 in adipose tissue remodeling and metabolic dysfunction

Background/objectives Proinflammatory cytokines are increased in obese adipose tissue, including inflammasome key masters. Conversely, IL-18 protects against obesity and metabolic dysfunction. We focused on the IL-18 effect in controlling adipose tissue remodeling and metabolism. Materials/subjects and methods We used C57BL/6 wild-type (WT) and interleukine-18 deficient (IL-18 −/− ) male mice fed a chow diet and samples from bariatric surgery patients. Results IL-18 −/− mice showed increased adiposity and proinflammatory cytokine levels in adipose tissue, leading to glucose intolerance. IL-18 was widely secreted by stromal vascular fraction but not adipocytes from mice’s fatty tissue. Chimeric model experiments indicated that IL-18 controls adipose tissue expansion through its presence in tissues other than bone marrow. However, IL-18 maintains glucose homeostasis when present in bone marrow cells. In humans with obesity, IL-18 expression in omental tissue was not correlated with BMI or body fat mass but negatively correlated with IRS1 , GLUT-4 , adiponectin, and PPARy expression. Also, the IL-18RAP receptor was negatively correlated with IL-18 expression. Conclusions IL-18 signaling may control adipose tissue expansion and glucose metabolism, as its absence leads to spontaneous obesity and glucose intolerance in mice. We suggest that resistance to IL-18 signaling may be linked with worse glucose metabolism in humans with obesity.